Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis

Status Completed

Clinical Trial Summary

Our study will evaluate the efficacy of early PPV in acute endophthalmitis and attempt to prove its greater effectiveness for combating infection when compared to eyes that received only intravitreal antibiotic therapy

Clinical Trial Description

Endophthalmitis, a severe inflammatory ocular condition with profound visual impairment that can lead to irreversible visual loss, requires immediate treatment. The only multicenter randomized trial of different forms of acute endophthalmitis treatment was the Endophthalmitis Vitrectomy Study. The study concluded that intravitreal antibiotic injection improves visual prognosis, and pars plana vitrectomy (PPV) improves the final visual acuity (VA) when performed in patients with light perception or worse VA. Our study will evaluate the efficacy of early PPV in acute endophthalmitis and attempt to prove its greater effectiveness for combating infection when compared to eyes that received only intravitreal antibiotic therapy. Primary Endpoint: The final VA, ocular anatomy, retinal layer anatomy, and ERG response in the intravitreal injection group will be compared with the PPV group. Secondary Endpoint: The final VA, eyeball anatomy, retinal layer anatomy, and ERG response in the group that underwent PPV will be compared with and without oral moxifloxacin therapy. ;

Study Design

Related Conditions & MeSH terms

Endophthalmitis

Clinical Trial Details

NCT number	NCT04192994
Study type	Interventional
Source	Federal University of São Paulo
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2019
Completion date	December 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04214821` - The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%	Phase 1/Phase 2
Completed	`NCT00461656` - Povidone-iodine Antisepsis for Strabismus Surgery	Phase 4
Completed	`NCT00136344` - Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery	N/A
Completed	`NCT04568213` - Hypochlorous Acid Disinfection Prior to Cataract Surgery	Phase 3
Terminated	`NCT01496794` - Endophthalmitis Cultures	N/A
Completed	`NCT00406913` - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery	N/A
Recruiting	`NCT05079854` - Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis	Phase 4
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Recruiting	`NCT02810587` - Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics	N/A
Completed	`NCT00398658` - Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis	Phase 4
Recruiting	`NCT04035369` - Endophthalmitis Post Intravitreal Injections	N/A
Not yet recruiting	`NCT03420820` - Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection	N/A
Recruiting	`NCT06268561` - Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
Withdrawn	`NCT00335231` - Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery	N/A
Not yet recruiting	`NCT03244072` - Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery	Phase 2/Phase 3
Completed	`NCT01323868` - Endogenous Endophthalmitis in the Inpatient Setting	N/A
Completed	`NCT03363295` - Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis	Phase 4
Suspended	`NCT02590523` - Intracameral Antibiotic Safety Study	Phase 3
Terminated	`NCT02770729` - Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.	Phase 3
Not yet recruiting	`NCT02324166` - Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain	Phase 4